← Open Payments lookup

USHA NATESAN: Open Payments

NPI 1336160290 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,083 in 48 payments from 17 companies in 2025. Trend: 2023 $425 · 2024 $772 · 2025 $1,083

Food & beverage: $938Education: $145
CompanyPaymentsAmount
Amgen Inc.8$248
Lilly USA, LLC8$173
Novo Nordisk Inc6$114
Astellas Pharma US Inc1$100
Takeda Pharmaceuticals U.S.A., Inc.6$98
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
PFIZER INC.2$38
Sumitomo Pharma America, Inc.2$38
Dexcom, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35

Products named: REPATHA, TRINTELLIX, MOUNJARO, Wegovy, OTEZLA, JARDIANCE, GEMTESA, Dexcom G6 Transmitter.

Industry payments across MD — which companies pay providers there.